18f

Documents about 18f

• 18F-fluorocholine PET/CT Imaging in Hyperparathyroidism#804997ClinicalTrials.gov
• Clinical Benefit of 18F-FET in Glioma.#846435ClinicalTrials.gov
• To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma#886865ClinicalTrials.gov
• Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma#917139ClinicalTrials.gov
• 16 U.S.C. § 18f-1 — Transferred#572979US Code (LII)
• 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients#981629ClinicalTrials.gov
• 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer#852062ClinicalTrials.gov
• Evaluation of [18F]-FMISO for Non Operated Glioblastoma#813165ClinicalTrials.gov
• A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer#875598ClinicalTrials.gov
• Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections#849575ClinicalTrials.gov
• 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer#907957ClinicalTrials.gov
• 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology#912542ClinicalTrials.gov
• Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury#872413ClinicalTrials.gov
• Molecular Pituitary Imaging Using 18F-FET PET#825191ClinicalTrials.gov
• 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism#843738ClinicalTrials.gov
• 16 U.S.C. § 18f — Repealed. Pub. L. 113–287, § 7, Dec. 19, 2014, 128 Stat. 3272#572978US Code (LII)
• A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma#842496ClinicalTrials.gov
• 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology#861789ClinicalTrials.gov
• MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imaging#893673ClinicalTrials.gov
• Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET#909882ClinicalTrials.gov
• Detection of Graft Versus Host Disease With [18F]F-AraG#992215ClinicalTrials.gov
• 16 U.S.C. § 18f-2 — Repealed. Pub. L. 113–287, § 7, Dec. 19, 2014, 128 Stat. 3272#572980US Code (LII)
• 16 U.S.C. § 18f-3 — Repealed. Pub. L. 113–287, § 7, Dec. 19, 2014, 128 Stat. 3272#572981US Code (LII)
• 18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes#804905ClinicalTrials.gov
• Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol#910424ClinicalTrials.gov
• Data to 18F-AW09#647809RODARE
• Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET#800615ClinicalTrials.gov
• 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety#835612ClinicalTrials.gov
• Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07#855583ClinicalTrials.gov
• A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms#890376ClinicalTrials.gov
• 18F-mFBG Cardiac Uptake With Lewy Body Dementia#968534ClinicalTrials.gov
• Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients#981436ClinicalTrials.gov
• 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma#860217ClinicalTrials.gov
• Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors#861274ClinicalTrials.gov
• [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma#908533ClinicalTrials.gov
• Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy#67866ClinicalTrials.gov
• 18F-Florbetaben PET Detection of Cardiac and Multi-Organ Involvement for Identifying AL and ATTR Cardiac Amyloidosis#312055HAL (France)
• Carotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR#901373ClinicalTrials.gov
• Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.#903522ClinicalTrials.gov
• Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer#916850ClinicalTrials.gov
• Radiomics analysis of [18F]-fluorodeoxyglucose-avid thyroid incidentalomas improves risk stratification and selection for clinical assessment#250627IRIS
• [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer#833202ClinicalTrials.gov
• 18F-AV-1451 Autopsy Study#888622ClinicalTrials.gov
• Using 18F- FDG,18F-DOPA and 68Ga-DOTATATE PET/CT in Detection and Evaluation of Response in Patients With NET Undergoing PRRT#863977ClinicalTrials.gov
• Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy#872851ClinicalTrials.gov
• Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors#890155ClinicalTrials.gov
• PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)#909090ClinicalTrials.gov
• Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients#860863ClinicalTrials.gov
• Flortaucipir 18F PET Imaging in BIOCARD Study#886941ClinicalTrials.gov
• Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007#832927ClinicalTrials.gov